SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 528.51 |
Enterprise Value ($M) | 389.82 |
Book Value ($M) | 667.93 |
Book Value / Share | 3.06 |
Price / Book | 0.79 |
NCAV ($M) | 662.84 |
NCAV / Share | 3.04 |
Price / NCAV | 0.80 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.16 |
Return on Assets (ROA) | -0.14 |
Return on Equity (ROE) | -0.15 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 48.63 |
Current Ratio | 48.63 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 681.39 |
Assets | 686.49 |
Liabilities | 18.55 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Deep Track Capital, LP | 5.26 | ||
13G/A | Castle Creek Arbitrage, LLC | 0.10 | ||
13G | Vanguard Group Inc | 5.17 | ||
13G/A | Fmr Llc | 14.54 | -1.91 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
59,620 | 365,021 | 16.33 | |
33,667 | 255,308 | 13.19 | |
68,384 | 438,155 | 15.61 | |
24,696 | 175,824 | 14.05 | |
21,474 | 382,546 | 5.61 | |
(click for more detail) |
Similar Companies | |
---|---|
LLY – Eli Lilly And Co | MRK – Merck & Co., Inc. |
MYOV – Myovant Sciences Ltd. | NVO – Novo-Nordisk A/S |
NVS – Novartis AG |
Financial data and stock pages provided by
Fintel.io